Zion Market Research reported that the global human microbiome market will be worth over $1.3 billion by the end of 2024, and probiotics is anticipated to dominate the product segment of this market.
uBiome, located in San Francisco CA, is developing a system for determining the nose microbiome. The system can additionally determine therapies for nasal-related conditions.
